SCHEMBL4437330

SCHEMBL4437330

O=C(c1cccc(Cl)c1)N1CCc2cc(C(=O)N3CCN4CCCCC4C3)ccc2C1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.59
ALDH1A1 P00352 2/20 0.59
KDM4E B2RXH2 1/20 0.59
PDE4B Q07343 1/20 0.54
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
KDM2B Q8NHM5 2/20 0.47
CCNK O75909 1/20 0.46
CDK12 Q9NYV4 1/20 0.46
L3MBTL3 Q96JM7 3/20 0.46
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
PRKCB P05771 1/20 0.44
KCNH2 Q12809 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
CACNA1H O95180 1/20 0.44
HTT P42858 1/20 0.44
MGLL Q99685 1/20 0.43
NAMPT P43490 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4530572 0.91 PDE4B (0.52) L3MBTL1ALDH1A1KDM4EPDE4BKMT2A
SCHEMBL4429416 0.91 KDM4E (0.71) L3MBTL1ALDH1A1KDM4EPDE4BMEN1
SCHEMBL4430623 0.90 ALDH1A1 (0.53) L3MBTL1ALDH1A1KDM4EPDE4BMEN1
SCHEMBL4437242 0.90 KDM4E (0.66) L3MBTL1ALDH1A1KDM4EPDE4BMEN1
SCHEMBL4431774 0.89 L3MBTL1 (0.62) L3MBTL1ALDH1A1KDM4EPDE4BMEN1
SCHEMBL14080700 0.89 ENPP2 (0.47) L3MBTL1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL4438634 0.89 HTT (0.59) L3MBTL1ALDH1A1KDM4EL3MBTL3KCNH2
SCHEMBL4524891 0.87 LMNA (0.54) L3MBTL1ALDH1A1KDM4EPDE4BCCNK
SCHEMBL4523572 0.86 MGLL (0.47) L3MBTL1PDE4BL3MBTL3KCNH2HRH3
SCHEMBL4518846 0.86 PDE4B (0.59) ALDH1A1KDM4EPDE4BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125741-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR Janssen Pharmaceutica, N.V. (BE) 2009-12-02 EP claimed
US-20090099158-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-16 US claimed
WO-2008109336-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-09-12 WO claimed
US-20090099158-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-16 US disclosed
US-20090099158-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-16 US disclosed
US-20090099158-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-16 US disclosed
WO-2008109336-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099158-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR HRH3, HRH4, HRH1 L3MBTL1 2302/4885ALDH1A1 3918/4885KDM4E 1117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.